Copyright
©The Author(s) 2019.
World J Meta-Anal. Feb 22, 2019; 7(2): 51-65
Published online Feb 22, 2019. doi: 10.13105/wjma.v7.i2.51
Published online Feb 22, 2019. doi: 10.13105/wjma.v7.i2.51
Study | Risk of bias | Applicability concerns | ||||||
Patient selection | Index test | Reference standard | Flow and timing | Patient selection | Index test | Reference standard | ||
Iwamoto et al[29], 2010 | L | U | H | L | L | L | L | |
Piludu et al[30], 2015 | L | U | U | L | L | L | L | |
Kalpathy-Cramer et al[31], 2017 | L | U | U | L | L | L | L | |
O’Neill et al[32], 2016 | L | U | H | L | L | L | L | |
Schmainda et al[4], 2014 | L | U | U | L | L | L | L | |
Hilario et al[33], 2016 | L | U | U | L | L | L | L |
- Citation: Kasenene A, Baidya A, Shams S, Xu HB. Evaluation of tumor response to antiangiogenic therapy in patients with recurrent gliomas using contrast-enhanced perfusion-weighted magnetic resonance imaging techniques: A meta-analysis. World J Meta-Anal 2019; 7(2): 51-65
- URL: https://www.wjgnet.com/2308-3840/full/v7/i2/51.htm
- DOI: https://dx.doi.org/10.13105/wjma.v7.i2.51